Geoffrey HodgeChief Technical Officer at Unum Therapeutics
Geoff is responsible for leading the development and execution of Unum’s CMC and technical operations, including process and analytical development, manufacturing, and quality, for the company’s proprietary antibody-coupled T-cell receptor (ACTR) therapies. He has over 25 years of experience in the biotechnology industry, providing bioprocessing technical solutions for companies including Millennium Pharmaceuticals, Genetics Institute (Wyeth), and Alpha-Beta Technology. Prior to joining Unum, Geoff was a co-founder of Xcellerex, inventor on several of Xcellerex’s foundational single-use technology patents, and an operations leader at Xcellerex / GE Healthcare Lifesciences. He holds an M.S. from WPI and bachelor’s degree from Colgate.